Literature DB >> 8386368

Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA.

A V Gudkov1, C R Zelnick, A R Kazarov, R Thimmapaya, D P Suttle, W T Beck, I B Roninson.   

Abstract

Many cytotoxic anticancer drugs act at topoisomerase II (topo II) by stabilizing cleavable complexes with DNA formed by this enzyme. Several cell lines, selected for resistance to topo II-interactive drugs, show decreased expression or activity of topo II, suggesting that such a decrease may be responsible for drug resistance. In the present study, etoposide resistance was used as the selection strategy to isolate genetic suppressor elements (GSEs) from a retroviral library expressing random fragments of human topo II (alpha form) cDNA. Twelve GSEs were isolated, encoding either peptides corresponding to short segments of the topo II alpha molecule (2.4-6.5% of the protein) or 163- to 220-bp-long antisense RNA sequences. Expression of a GSE encoding antisense RNA led to decreased cellular expression of the topo II alpha protein. Both types of GSE induced resistance to several topo II poisons but not to drugs that do not act at topo II. These results provide direct evidence that inhibition of topo II results in resistance to topo II-interactive drugs, indicate structural domains of topo II capable of independent functional interactions, and demonstrate that expression selection of random fragments constitutes an efficient approach to the generation of GSEs in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386368      PMCID: PMC46273          DOI: 10.1073/pnas.90.8.3231

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  DNA topoisomerase II immunostaining in human leukemia and rhabdomyosarcoma cell lines and their responses to topoisomerase II inhibitors.

Authors:  J S Wolverton; M K Danks; B Granzen; W T Beck
Journal:  Cancer Res       Date:  1992-08-01       Impact factor: 12.701

2.  DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage.

Authors:  C Holm; T Stearns; D Botstein
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

3.  Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22.

Authors:  M Tsai-Pflugfelder; L F Liu; A A Liu; K M Tewey; J Whang-Peng; T Knutsen; K Huebner; C M Croce; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

4.  Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.

Authors:  H Zhang; J C Wang; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

Review 5.  DNA topoisomerases.

Authors:  J C Wang
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

6.  Construction and use of a safe and efficient amphotropic packaging cell line.

Authors:  D Markowitz; S Goff; A Bank
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

Review 7.  Functional inactivation of genes by dominant negative mutations.

Authors:  I Herskowitz
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

8.  Association of DNA topoisomerase I and RNA polymerase I: a possible role for topoisomerase I in ribosomal gene transcription.

Authors:  K M Rose; J Szopa; F S Han; Y C Cheng; A Richter; U Scheer
Journal:  Chromosoma       Date:  1988       Impact factor: 4.316

9.  Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro.

Authors:  L Yang; M S Wold; J J Li; T J Kelly; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

10.  Structure of the Drosophila DNA topoisomerase II gene. Nucleotide sequence and homology among topoisomerases II.

Authors:  E Wyckoff; D Natalie; J M Nolan; M Lee; T Hsieh
Journal:  J Mol Biol       Date:  1989-01-05       Impact factor: 5.469

View more
  42 in total

1.  Establishment of a chemical synthetic lethality screen in cultured human cells.

Authors:  A Simons; N Dafni; I Dotan; Y Oron; D Canaani
Journal:  Genome Res       Date:  2001-02       Impact factor: 9.043

2.  A functional genetic screen identifies regions at the C-terminal tail and death-domain of death-associated protein kinase that are critical for its proapoptotic activity.

Authors:  T Raveh; H Berissi; M Eisenstein; T Spivak; A Kimchi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

3.  A rapid genetic screening system for identifying gene-specific suppression constructs for use in human cells.

Authors:  G M Arndt; M Patrikakis; D Atkins
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

4.  Reversal of human cellular senescence: roles of the p53 and p16 pathways.

Authors:  Christian M Beauséjour; Ana Krtolica; Francesco Galimi; Masashi Narita; Scott W Lowe; Paul Yaswen; Judith Campisi
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

5.  Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.

Authors:  Michael F Press; Guido Sauter; Marc Buyse; Leslie Bernstein; Roberta Guzman; Angela Santiago; Ivonne E Villalobos; Wolfgang Eiermann; Tadeusz Pienkowski; Miguel Martin; Nicholas Robert; John Crown; Valerie Bee; Henry Taupin; Kerry J Flom; Isabelle Tabah-Fisch; Giovanni Pauletti; Mary-Ann Lindsay; Alessandro Riva; Dennis J Slamon
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

6.  Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.

Authors:  T A Järvinen; M Tanner; V Rantanen; M Bärlund; A Borg; S Grénman; J Isola
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 7.  Targeting DNA topoisomerase II in cancer chemotherapy.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

8.  Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains.

Authors:  V S Ossovskaya; I A Mazo; M V Chernov; O B Chernova; Z Strezoska; R Kondratov; G R Stark; P M Chumakov; A V Gudkov
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  Genetic synthetic lethality screen at the single gene level in cultured human cells.

Authors:  A H Simons; N Dafni; I Dotan; Y Oron; D Canaani
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

10.  Dual functions of the homeoprotein DLX4 in modulating responsiveness of tumor cells to topoisomerase II-targeting drugs.

Authors:  Bon Q Trinh; Song Yi Ko; Nicolas Barengo; Shiaw-Yih Lin; Honami Naora
Journal:  Cancer Res       Date:  2012-12-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.